Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model

Brain Research

Volumn 862, Issue 1-2, 2000, Pages 247-252

  Kim, Hyoung Chun ^a   Jhoo, Wang Kee ^a   Shin, Eun Joo ^a   Bing, Guoying ^b  

^a Department of Pharmacy   (South Korea)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Dietary selenium; Dopamine; Methamphetamine; Neurotoxicity; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; METHAMPHETAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN TOXICITY; CELL DAMAGE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; MALE; MOUSE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; SELENIUM DEFICIENCY; SHORT SURVEY; SUBSTANTIA NIGRA; THERMOREGULATION;

EID: 0034678558     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02085-0     Document Type: Article

References (24)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:1946;239-247.
2. Albers D.S., Sonsalla P.K. Methamphetamine-induced hypertermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 27:1995;1104-1114.
3. Ben-Shachar D., Eshel G., Riederer P., Youdim M.B.H. Role of iron and iron chelation in dopaminergic-induced neurodegeneration: implication for Parkinson's disease. Ann. Neurol. 32:1992;S105-S110.
4. Bing G., Zhang Y., Watanabe Y., McEwen B.S., Stone E.A. Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra. Brain Res. 668:1994;261-265.
5. Bose R., Schell C.L., Pinsky C., Zitko V. Effect of excitotoxin on free radical indices in mouse brain. Toxicol. Lett. 60:1992;211-219.
6. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker Jr W., Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268:1994;1571-1580.
7. Castano A., Cano J., Machado A. Low selenium diet affects monoamine turnover differentially in substantia nigra and striatum. J. Neurochem. 61:1993;1302-1307.
8. Chareon-Kawamoto N., Yasumoto K. Selenium deficiency as a cause of overload iron and unbalanced distribution of other minerals. Biosci. Biotechnol. Biochem. 59:1995;302-306.
9. Cubells J.F., Rayport S., Rajendran G., Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14:1994;2260-2271.
10. De Vito M.J., Wagner G.C. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology. 28:1989;1145-1150.
11. Ewan R.C. Effects of selenium on rat growth, growth hormone and diet utilization. J. Nutr. 106:1976;702-709.
12. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
13. Huang K., Lauridsen E., Clausen J. The uptake of Na-selenite in rat brain. Biol. Trace Elem. Res. 46:1994;91-102.
14. Imam S.Z., Newport G.D., Islam F. Jr., Slikker W., Ali S.F. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res. 818:1999;575-578.
15. Jayanthi S., Ladenheim B., Cadet J.L. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann. NY Acad. Sci. 844:1998;92-102.
16. Kim H.C., Jhoo W.K., Choi D.Y., Im D.H., J Shin E., Suh J.H., Floyd R.A., Bing G. Protection of methamphetamine nigrostriatal toxicity by dietary selenium. Brain Res. 851:1999;76-86.
17. Moszczynska A., Turenne S., Kish S.J. Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine. Neurosci. Lett. 255:1998;49-52.
18. Moy L.Y., Albers D.S., Sonsalla P.K. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice. Brain Res. 790:1998;264-269.
19. Nutrient Requirement of Laboratory Animals: Mouse. 1978;38-53 National Academic Press, Washington, DC.
20. Rafalowska U., Liu G.L., Floyd R.A. Peroxidation induced changes in synaptosomal transport of dopamine and gamma-aminobutyric acid. Free Radic. Biol. Med. 6:1989;485-492.
21. Schmidt C.J., Ritter J.K., Sonsalla P.K., Hanson G.R., Gibb J.W. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233:1985;539-544.
22. Seiden L.S., Vosmer G. Formation of 6-hydroxydopamine in caudate nucleus of the rat after a single large dose of methylamphetamine. Pharmacol. Biochem. Behav. 21:1984;29-31.
23. Sonsalla P.K., Jochnowitz N.D., Zeevalk G.D., Oostveen J.A., Hall E.D. Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Res. 738:1996;172-175.
24. Sutphin M.S., Buckman T.D. Effects of low selenium diets on antioxidant status and MPTP toxicity in mice. Neurochem. Res. 16:1991;1257-1263.